Ignite Creation Date:
2024-05-05 @ 9:42 AM
Last Modification Date:
2024-10-26 @ 9:04 AM
Study NCT ID:
NCT00004078
Status:
COMPLETED
Last Update Posted:
2013-06-14
First Post:
1999-12-10
Brief Title:
Irinotecan in Treating Children With Refractory Solid Tumors
Sponsor:
Childrens Oncology Group
Organization:
Childrens Oncology Group
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Unspecified Childhood Solid Tumor Protocol Specific |
| Childhood Central Nervous System Germ Cell Tumor |
| Childhood Choroid Plexus Tumor |
| Childhood Craniopharyngioma |
| Childhood Grade I Meningioma |
| Childhood Grade II Meningioma |
| Childhood Grade III Meningioma |
| Childhood Infratentorial Ependymoma |
| Childhood Oligodendroglioma |
| Childhood Supratentorial Ependymoma |
| Previously Treated Childhood Rhabdomyosarcoma |
| Recurrent Childhood Cerebellar Astrocytoma |
| Recurrent Childhood Cerebral Astrocytoma |
| Recurrent Childhood Ependymoma |
| Recurrent Childhood Medulloblastoma |
| Recurrent Childhood Rhabdomyosarcoma |
| Recurrent Childhood Visual Pathway and Hypothalamic Glioma |
| Recurrent Childhood Visual Pathway Glioma |
| Recurrent Ewing SarcomaPeripheral Primitive Neuroectodermal Tumor |
| Recurrent Neuroblastoma |
| Recurrent Osteosarcoma |
Keywords: